title: Vernal Keratoconjunctivitis and immune-mediated diseases: One unique way to symptom control?
authors.affiliation: Department of Pediatrics, Policlinico Umberto I -'Sapienza' University of Rome, Rome, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Occasi
authors.affiliation: Department of Pediatrics, Policlinico Umberto I -'Sapienza' University of Rome, Rome, Italy.
authors.forename: Anna Maria
authors.initials: AM
authors.lastname: Zicari
authors.affiliation: Department of Pediatrics, Policlinico Umberto I -'Sapienza' University of Rome, Rome, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: Petrarca
authors.affiliation: Department of Sense Organs, Policlinico Umberto I -'Sapienza' University of Rome, Rome, Italy.
authors.forename: Marcella
authors.initials: M
authors.lastname: Nebbioso
authors.affiliation: Department of Medical and Surgical Neonatology, 'Bambino Gesù' Children's Hospital, Rome, Italy.
authors.forename: Guglielmo
authors.initials: G
authors.lastname: Salvatori
authors.affiliation: Department of Pediatrics, Policlinico Umberto I -'Sapienza' University of Rome, Rome, Italy.
authors.forename: Marzia
authors.initials: M
authors.lastname: Duse
mesh_terms: D000293:Adolescent; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D003233:Conjunctivitis, Allergic / Q000188:drug therapy* / Q000276:immunology; D016572:Cyclosporine / Q000008:administration & dosage; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000276:immunology; D018450:Disease Progression; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D008297:Male; D000069444:Omalizumab / Q000008:administration & dosage*; D018417:Th1 Cells / Q000187:drug effects* / Q000276:immunology; D018418:Th2 Cells / Q000187:drug effects* / Q000276:immunology
chemical_list: D000069444:Omalizumab; D007073:Immunoglobulin E; D016572:Cyclosporine